Valuation: LifeVantage Corporation

Market Cap 74.29M 66.67M 61.56M 55.83M 104M 7.06B 106M 738M 293M 3.7B 279M 273M 11.73B P/E 2027 *
30.4x
P/E 2028 * 18.8x
Enterprise Value 61.6M 55.29M 51.05M 46.29M 86.53M 5.85B 87.59M 612M 243M 3.07B 231M 226M 9.73B EV / Sales 2027 *
0.37x
EV / Sales 2028 * 0.35x
Free-Float
86.31%
Yield 2027 *
-
Yield 2028 * -
1 day+2.95%
1 week-0.67%
Current month-5.87%
1 month-5.27%
3 months-6.91%
6 months+7.62%
Current year-3.73%
1 week 5.53
Extreme 5.5274
6.01
1 month 5.3
Extreme 5.295
6.4
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
11.71
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 63 05/08/2026
Director of Finance/CFO 53 25/10/2021
Chief Tech/Sci/R&D Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 74 01/01/2012
Director/Board Member 67 01/02/2017
Director/Board Member 68 17/02/2022
Date Insider Type Main position Quantity % Market Cap. Importance
7/10/26 Free

Chief Financial Officer

89,372 0.7099%
7/10/26 Free

Responsable ventes & marketing

82,125 0.6523%
7/10/26 Free

Chief Executive Officer

483,092 3.8373%
Change 5-day change 1-year change 3-year change Capi.($)
+2.95%-0.67%-30.48%-23.97% 74.29M
+0.22%-0.14%+55.12%+128.82% 1,143B
+0.91%+3.61%+41.21%+84.57% 647B
-0.12%-0.93%+25.59%+106.14% 506B
-0.99%+0.48%+50.86%+63.24% 384B
+0.86%-4.37%+61.16%+37.93% 350B
+0.07%+1.45%+30.19%+52.10% 293B
-0.64%+0.95%+2.64%+24.62% 265B
+0.75%+2.05%+53.85%+71.25% 242B
+0.25%+1.64%+32.05%+107.62% 197B
Average -0.17%+0.69%+32.22%+65.23% 402.76B
Weighted average by Cap. -0.70%+0.71%+42.82%+87.77%

Financials

2027 *2028 *
Net sales 165M 148M 137M 124M 232M 15.72B 235M 1.64B 653M 8.24B 621M 608M 26.12B 168M 150M 139M 126M 236M 15.93B 238M 1.67B 662M 8.35B 629M 616M 26.47B
Net income 2.49M 2.23M 2.06M 1.87M 3.5M 236M 3.54M 24.72M 9.82M 124M 9.34M 9.14M 393M 4M 3.59M 3.31M 3M 5.61M 380M 5.68M 39.71M 15.77M 199M 15M 14.68M 631M
Net Debt -12.68M -11.38M -10.51M -9.53M -17.81M -1.2B -18.03M -126M -50.05M -631M -47.61M -46.59M -2B -14.88M -13.35M -12.33M -11.18M -20.9M -1.41B -21.15M -148M -58.71M -741M -55.85M -54.66M -2.35B
Projected Income Statement - Annual - LifeVantage Corporation
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
216
Date Price Change Volume
27/10/26 USD 5.930 +2.95% 16,448
26/10/26 USD 5.760 -1.71% 24,233
23/10/26 USD 5.860 -2.01% 23,751
22/10/26 USD 5.980 +0.50% 31,374
21/10/26 USD 5.950 -0.34% 30,297
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - LifeVantage Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.930USD
Average target price
7.500USD
Spread / Average Target
+26.48%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LifeVantage Corporation
  1. Stock Market
  2. Stocks
  3. LFVN Stock